AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2022
Feb 8, 2022
30237_dirs_2022-02-08_b70184ec-98a6-478d-ad68-98d0dd2530b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2022-02-04
Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-04 | Common Stock | M | 560 | — | Acquired | 6961.4989 | Direct |
| 2022-02-04 | Common Stock | F | 152 | $277.48 | Disposed | 6809.4989 | Direct |
| 2022-02-07 | Common Stock | S | 204 | $277.38 | Disposed | 6605.4989 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-04 | Restricted Stock Unit | $ | M | 560 | Disposed | Common Stock (560) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Stock withholding to satisfy tax withholding obligations.
F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021.
F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.